AMSTERDAM, Oct. 12, 2021 /PRNewswire/ -- VEON Ltd. (NASDAQ:
VEON) (Euronext Amsterdam: VEON), a leading global provider of
connectivity and internet services, today announces
that its mobile operator in Russia, Beeline, has
signed an agreement with Sechenov University to
create an Artificial Intelligence
(AI) Laboratory for research and
development into new technology solutions
for healthcare, aiming to simplify and
accelerate high-precision diagnostic.
The new AI Laboratory will see data
scientists and doctors collaborate on research and
development of predictive medicine solutions in
traumatology and oncology. Over
120 professionals from Beeline and Sechenov
University, including data scientists, solution
architects, neural network programmers and medical
experts, will be involved in the new AI Lab to provide a
critical mass of expertise. The AI
Labs will undertake specific research
programmes, scientific exchange and staff
secondments, with IT infrastructure provided by Beeline's
datacentres.
"Technology based on artificial
intelligence is transforming modern
medicine," states Kaan
Terzioglu, CEO of VEON Group. "We have invested in AI
at the core of
our digital operator businesses and are proud
of our contribution to the development of state-of-the-art
technology. This will be a game-changer in the way we
support medical institutions, save lives and
keep people healthy throughout their lifetime."
"This joint AI Lab will enable smart software
solutions to be trained by findings from some of the best
doctors in the industry and so help to significantly
simplify and expedite high-precision
diagnostics processes," said Evgeny Chereshnev,
Executive Vice President of Beeline for Digital and New Business
Development. "This greatly increases the chances
of successful treatment of patients, and sometimes,
literally saves lives. Our partnership with
Sechenov University is a new direction for
Beeline which is already yielding
results. Sechenov's experts are some of
the best in the world, and we are delighted to
be working with them to develop and apply high-tech
solutions."
"Our partnership with Beeline began earlier this year. In
particular, we focused on the study of joint pathology in
the framework of Laboratory of Smart Nanotechnology for Clinical
Applications supported by Megagrant from
Ministry of Science and Higher Education of the Russian Federation. Based on the analysis of
more than 4,000 medical records, we managed to create a model that
determines the type of pathology and its localization
with over 80% accuracy. This technological solution can
help doctors significantly accelerate the process of diagnosing
joint pathologies and its accuracy, and also makes it
possible to predict the possible disease, track the
effectiveness of treatment and dynamically make adjustments
to it. For a patient, this can open the way
for timely help and medical treatment instead
of surgery," explains Petr Glybochko,
Academician of the Russian Academy of Sciences, prof., MD, Rector
of the Sechenov University. "The next step would be
to work with the Russian healthcare system to
test AI diagnostics in
a clinical environment. In the future, we plan
to extend our work to the field of cardiology,
immunology, pulmonology and post-covid therapy."
"The development of AI solutions in medicine and their
introduction into practical healthcare will enable
the solving of complex diagnostic problems at a new
level. New software solutions, based on the use of neural
networks and artificial intelligence will be integrated in
electronical medical records for the Russian Healthcare System. The
project will create a collaboration of IT engineers and
medical experts that builds the preconditions for a real
technological breakthrough. This can enable the creation
of "digital twins" and their introduction into clinical
practice. This is one of the main directions of development of
Sechenov University within the framework of the Priority 2030
project, which will be implemented thanks to the cooperation of
specialists from Sechenov University and VEON's Beeline," said
Petr Glybochko, Academician of the Russian Academy of
Sciences, prof., MD, Rector of the Sechenov University.
About VEON
VEON is a NASDAQ and Euronext Amsterdam-listed global provider
of connectivity and digital services. Our companies are
transforming lifestyles through technology-driven services that
empower opportunity in some of the world's fastest-growing emerging
markets. For more information, visit: https://www.veon.com
About Sechenov University
Sechenov University is the oldest medical school in Russia. Currently, it has more than 21,000
students (20% international). Teaching and research staff (2,263
people) work at 115 departments. Sechenov University has 23
research institutes, 6 of them form the Biomedical Science and
Technology Park. Sechenov University offers courses in clinical
medicine (general medicine, paediatrics, dentistry),
preventive medicine, pharmacy, nursing, social work, public health,
management, medical biophysics, medical biochemistry,
biotechnology, bioengineering and bioinformatics, clinical
psychology, defectology, linguistics, mathematical modelling,
IT, and materials science.
Disclaimer
This release contains "forward-looking statements", as the
phrase is defined in Section 27A of the U.S. Securities Act of
1933, as amended, and Section 21E of the U.S. Securities Exchange
Act of 1934, as amended. Forward-looking statements are not
historical facts, and include statements relating to, among other
things, expectations regarding management plans and future
performance. Forward-looking statements are inherently subject to
risks and uncertainties, many of which VEON cannot predict with
accuracy and some of which VEON might not even anticipate. The
forward-looking statements contained in this release speak only as
of the date of this release. VEON does not undertake to publicly
update, except as required by U.S. federal securities laws, any
forward-looking statement to reflect events or circumstances after
such dates or to reflect the occurrence of unanticipated
events.
Contact Information
Marina Levina
VEON Group
Group Communications Director
Marina.levina@veon.com
Julian Tanner
TUVA Partners
julian.tanner@tuvapartners.com
View original
content:https://www.prnewswire.com/news-releases/veons-beeline-and-leading-medical-institute-join-forces-to-redefine-future-of-medical-diagnostics-through-ai-301397682.html
SOURCE VEON Ltd